Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

被引：0

作者：

Advani, Anjali S. ^{[1
]}

Tse, William ^{[2
]}

Jia, Xuefei ^{[3
]}

Elson, Paul ^{[3
]}

Cooper, Brenda ^{[4
]}

Ali-Osman, Francis ^{[5
]}

Park, Jino ^{[2
]}

Rao, Arati V. ^{[6
]}

Rizzieri, David A. ^{[7
]}

Wang, Eunice S. ^{[8
]}

Cotta, Claudiu V. ^{[9
]}

Kalaycio, Matt ^{[10
]}

Sobecks, Ronald M. ^{[10
]}

Rouphail, Basel ^{[10
]}

Maciejewski, Jaroslaw P. ^{[11
]}

Fensterl, Jaime ^{[12
]}

Bailey, Laura ^{[12
]}

Carew, Jennifer S. ^{[13
]}

Foster, Bethany ^{[12
]}

Rush, Mary Lynn ^{[12
]}

Adams, Donna ^{[14
]}

Griffiths, Elizabeth A. ^{[8
]}

Sekeres, Mikkael A. ^{[1
]}

机构：

[1] Cleveland Clin, Leukemia Program, Cleveland, OH 44106 USA

[2] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA

[3] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA

[4] Case Western Reserve Univ, Univ Hosp Cleveland, Cleveland, OH 44106 USA

[5] Duke Univ, Durham, NC USA

[6] Duke Univ, Duke Canc Inst, Durham, NC USA

[7] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA

[8] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA

[9] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA

[10] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[11] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[12] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA

[13] Cleveland Clin, Taussig Canc Inst, Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[14] Duke Univ, Dept Med, Durham, NC USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3